 |
|
Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song
Clin Mol Hepatol. 2022;28(2):219-231. Published online 2021 Jul 20 DOI: https://doi.org/10.3350/cmh.2021.0082
|
|
Citations to this article as recorded by
 Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
Do Seon Song, U Im Chang, Jin Mo Yang
Clinical and Molecular Hepatology.2023; 29(1): 165. CrossRef Interaction between sarcopenia and nonalcoholic fatty liver disease
Sae Kyung Joo, Won Kim
Clinical and Molecular Hepatology.2023; 29(Suppl): S68. CrossRef Hematological and biochemical investigations on the effect of curcumin and Thymoquinone in male mice exposed to Thioacetamide
Atef M. Al-Attar
Saudi Journal of Biological Sciences.2022; 29(1): 660. CrossRef A Review of Sarcopenia Pathophysiology, Diagnosis, Treatment and Future Direction
Myung-Rae Cho, Sungho Lee, Suk-Kyoon Song
Journal of Korean Medical Science.2022;[Epub] CrossRef Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
Takumi Kawaguchi, Takuji Torimura
Clinical and Molecular Hepatology.2022; 28(2): 177. CrossRef
|